These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8875468)

  • 1. Apolipoprotein E distribution among different plaque types in Alzheimer's disease: implications for its role in plaque progression.
    Sheng JG; Mrak RE; Griffin WS
    Neuropathol Appl Neurobiol; 1996 Aug; 22(4):334-41. PubMed ID: 8875468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution.
    Griffin WS; Sheng JG; Roberts GW; Mrak RE
    J Neuropathol Exp Neurol; 1995 Mar; 54(2):276-81. PubMed ID: 7876895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between apolipoprotein E and the amyloid deposits and dystrophic neurites of Alzheimer's disease.
    Dickson TC; Saunders HL; Vickers JC
    Neuropathol Appl Neurobiol; 1997 Dec; 23(6):483-91. PubMed ID: 9460714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease.
    Mrak RE; Sheng JG; Griffin WS
    J Neuropathol Exp Neurol; 1996 Mar; 55(3):273-9. PubMed ID: 8786385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms.
    Sheng JG; Mrak RE; Griffin WS
    Acta Neuropathol; 1997 Jul; 94(1):1-5. PubMed ID: 9224523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
    He SR; Liu DG; Wang S; Xia YJ
    Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner.
    Thal DR; Capetillo-Zarate E; Schultz C; Rüb U; Saido TC; Yamaguchi H; Haass C; Griffin WS; Del Tredici K; Braak H; Ghebremedhin E
    Acta Neuropathol; 2005 Nov; 110(5):459-71. PubMed ID: 16195918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of differential immune factors in temporal cortex and cerebellum: the role of alpha-1-antichymotrypsin, apolipoprotein E, and reactive glia in the progression of Alzheimer's disease.
    Styren SD; Kamboh MI; DeKosky ST
    J Comp Neurol; 1998 Jul; 396(4):511-20. PubMed ID: 9651008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astrocyte-apolipoprotein E associations in senile plaques in Alzheimer disease and vascular lesions: a regional immunohistochemical study.
    Shao Y; Gearing M; Mirra SS
    J Neuropathol Exp Neurol; 1997 Apr; 56(4):376-81. PubMed ID: 9100668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease.
    Dickson TC; Vickers JC
    Neuroscience; 2001; 105(1):99-107. PubMed ID: 11483304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
    Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ
    Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution.
    Sheng JG; Mrak RE; Griffin WS
    Neuropathol Appl Neurobiol; 1995 Aug; 21(4):290-301. PubMed ID: 7494597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inconstant apolipoprotein E (ApoE)-like immunoreactivity in amyloid beta protein deposits: relationship with APOE genotype in aging brain and Alzheimer's disease.
    Uchihara T; Duyckaerts C; Lazarini F; Mokhtari K; Seilhean D; Amouyel P; Hauw JJ
    Acta Neuropathol; 1996 Aug; 92(2):180-5. PubMed ID: 8841664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of interleukin-1-immunoreactive microglia in cerebral cortical layers: implications for neuritic plaque formation in Alzheimer's disease.
    Sheng JG; Griffin WS; Royston MC; Mrak RE
    Neuropathol Appl Neurobiol; 1998 Aug; 24(4):278-83. PubMed ID: 9775393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plaque-associated neuronal proteins: a recurrent motif in neuritic amyloid deposits throughout diverse cortical areas of the Alzheimer's disease brain.
    Schmidt ML; DiDario AG; Otvos L; Hoshi N; Kant JA; Lee VM; Trojanowski JQ
    Exp Neurol; 1994 Dec; 130(2):311-22. PubMed ID: 7867760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of cytokine IL-1α and S100β in different types of plaques in Alzheimer's disease].
    Yao JJ; He SR; Chen L; Yang L; Qiao XB; Zhang W; Du J; Liu DG
    Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):581-4. PubMed ID: 22177239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ApoE immunoreactivity and microglial cells in Alzheimer's disease brain.
    Uchihara T; Duyckaerts C; He Y; Kobayashi K; Seilhean D; Amouyel P; Hauw JJ
    Neurosci Lett; 1995 Jul; 195(1):5-8. PubMed ID: 7478253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysosomal LAMP1 immunoreactivity exists in both diffuse and neuritic amyloid plaques in the human hippocampus.
    Hassiotis S; Manavis J; Blumbergs PC; Hattersley KJ; Carosi JM; Kamei M; Sargeant TJ
    Eur J Neurosci; 2018 May; 47(9):1043-1053. PubMed ID: 29570886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-evaluation of the structural organization of neuritic plaques in Alzheimer's disease.
    Masliah E; Mallory M; Deerinck T; DeTeresa R; Lamont S; Miller A; Terry RD; Carragher B; Ellisman M
    J Neuropathol Exp Neurol; 1993 Nov; 52(6):619-32. PubMed ID: 8229081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification in immunolocalization of a new class of proteoglycan (keratan sulfate) to the neuritic plaques of Alzheimer's disease.
    Snow AD; Nochlin D; Sekiguichi R; Carlson SS
    Exp Neurol; 1996 Apr; 138(2):305-17. PubMed ID: 8620929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.